Press Release

Aspect Magnet Technologies Announces Scientific Advisory Board Members

Four Scientific and Medical Imaging Leaders to Provide Counsel to the MRI Company

NETANYA, Israel -- Aug. 17, 2010

Aspect Magnet Technologies Ltd. announced today that it has formed a scientific advisory board to advise and help guide the company as it continues to develop a new generation of compact, affordable, easy-to-use magnetic resonance imaging (MRI) systems using its proprietary permanent magnet technology.

“The willingness of this distinguished group of international research imaging experts to come together to contribute their perspectives to the further development of our compact MRI systems shows the interest of preclinical researchers in having non-invasive imaging tools available directly in the lab,” said Uri Rapoport, founder and chief executive officer of Aspect. “There is clearly an important role that freestanding, compact MRI systems can play to accelerate research and enable new ways of gathering information.”

Joining the company’s scientific advisory board are:

  • Peter Bendel, Ph.D., is senior staff researcher at the Weizmann Institute of Science, where he supervises the nuclear magnetic resonance (NMR) and MRI facilities in the Department of Chemical Research Support. He has more than 30 years of experience in the field of MRI, including having worked as research and development physicist at Elscint, as a visiting scientist at the University of Tennessee Medical Center, and in the Corporate Research Laboratory of ExxonMobil.
  • Robert Lenkinski, Ph.D., is professor of Radiology at Harvard Medical School and a vice-chairman and director of Radiology Research at Beth Israel Deaconess Medical Center. Lenkinski is currently researching clinical applications of in vivo magnetic resonance spectroscopy and developing in vivo multinuclear MR imaging methods. He has authored numerous articles in peer-reviewed journals and has been awarded several patents.
  • G. Allan Johnson, Ph.D., is director of the Center for In Vivo Microscopy, an NIH/NCRR National Biomedical Technology Resource Center, and Charles E. Putman University Professor in radiology, physics, and biomedical engineering at Duke University. Johnson is the principal investigator of the Duke Molecular Imaging Center supported by the National Cancer Institute. A key research focus for Johnson is in magnetic resonance histology (MRH), the application of MR microscopy to the study of tissue architecture.
  • Gil Navon, Ph.D., is active professor emeritus of Chemistry at Tel Aviv University. He has contributed to the field of biomedical NMR from its beginning, having achieved many original breakthroughs in imaging of live cancer and bacterial cells, electrical currents, connective tissues and nerves. He is co-author on more than 250 peer-reviewed papers and has been awarded 12 patents.

The scientific advisory board members will provide ongoing input and feedback on the company’s products and technology development.

Aspect will be showcasing its MRI systems at the upcoming World Molecular Imaging Congress Sept. 8-11 in Kyoto, Japan at booth #410.


About Aspect

Aspect Magnet Technologies Ltd. designs, develops and manufactures compact high-resolution Magnetic Resonance Imaging (MRI) based systems. Through its equipment, Aspect enables life sciences and medical researchers in the pre-clinical market to speed scientific discovery and drug development by allowing them to perform in vivo small animal imaging and in vitro studies directly in their laboratories. Aspect’s breakthrough in permanent magnet technology and affordable, easy-to-use systems allows MRI to be used routinely by solving many drawbacks found in today’s MRI market, such as high unit cost, high cost of ownership, complex operation & installation. Aspect was founded in 2000 and is headquartered in Netanya, Israel. More information is available at

For further information, please contact:

Robert Sandler
SVP, Marketing
Aspect Magnet Technologies
T. +1 (416) 274 8166